Hi @Tanja thanks for posting this version of the study. I've attached the study information I had previously posted in a separate thread.
I would agree with you that based on this research (which BC Cancer participated in), that there is indeed evidence that long term PARB treatment should be supported. This study was focused on individuals that had experienced at least one recurrence and continued to be platinum-sensitive. Sadly, the piece the study did not investigate was "why" did this worked for them. Another study needs to be done for that element. Regardless, it's one more piece of data that we can use in our personal advocacy.
I did ask my gyne oncologist (Ontario based) if Lynparza would be an available option for someone who has a recurrence and who remained platinum-sensitive, and she said "no" however she also said that treatment options are changing all the time.
#Clinicaltrialsandresearch